A study by Wenjuan et al published in 2019 involved extracting radiomic features from mammograms and using deep learning algorithms to assess if these features were associated with particular molecular subtypes of breast cancer, such as HER2 positive or triple negative. The gene discussed is ERBB2; the disease is breast cancer.